MRP 80.25/-STRIP

Composition

Each uncoated bilayered tablet contains: Glimepiride IP 1 mg + Pioglitazone Hydrochloride IP Eq. to Pioglitazone 15 mg + Metformin Hydrochloride IP 500 mg (In Extended Release Form) + Excipients q.s. (DOUBLE COLOR)

Doses

As Directed by Physician

Description

This medication, containing Glimepiride, Pioglitazone, and Metformin, is a combination anti-diabetic drug used to control blood sugar levels in adults with type 2 diabetes when diet, exercise, and single-agent therapy are insufficient. 

Formulation

Tablet